In July, lurasidone—a dopamine receptor 2 (D2) blocker originally approved to treat schizophrenia—wa...
A recently released study of the influence of medical and scientific journals finds the American Jou...
In July, lurasidone—a dopamine receptor 2 (D2) blocker originally approved to treat schizophrenia—wa...
A recently released study of the influence of medical and scientific journals finds the American Jou...